abstract |
Formula I [Chemical 1] Wherein R 1 , R 6 , R 8 , Q 2 , Q 3 , Q 3a , Q 4 , L and A have the meanings given in the specification, and pharmaceutically acceptable salts thereof I will provide a. These compounds are useful in the treatment of diseases where it is desirable and / or necessary to inhibit the activity of members of the MAPEG family, particularly in the treatment of inflammation and / or cancer. [Selection figure] None |